ATP6AP2 and diabetic kidney disease: Combined actions from renin, prorenin, and (pro)renin receptor (PRR) contribute to the activation of the intratubular RAS, tubular interstitial damage [4–8], and diabetic nephropathy [4, 5, 9, 10].